These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18991236)

  • 81. Cortico-Striato-Thalamo-Cortical Circuitry, Working Memory, and Obsessive-Compulsive Disorder.
    Li B; Mody M
    Front Psychiatry; 2016; 7():78. PubMed ID: 27199785
    [No Abstract]   [Full Text] [Related]  

  • 82. Obsessive-compulsive disorder successfully treated with trazodone.
    Lydiard RB
    Psychosomatics; 1986 Dec; 27(12):858-9. PubMed ID: 3809382
    [No Abstract]   [Full Text] [Related]  

  • 83. Lack of efficacy of lithium augmentation in obsessive-compulsive disorder: the perspective of different regional effects of lithium on serotonin release in the central nervous system.
    Blier P; de Montigny C
    J Clin Psychopharmacol; 1992 Feb; 12(1):65-6. PubMed ID: 1552042
    [No Abstract]   [Full Text] [Related]  

  • 84. Treatment with aripiprazole and topiramate in an obese subject with borderline personality disorder, obsessive-compulsive symptoms and bulimia nervosa: a case report.
    Bruno A; Riganello D; Marino A
    Cases J; 2009 Jul; 2():7288. PubMed ID: 19829941
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Lithium treatment for obsessive-compulsive neuroses. A little clinical-therapeutic pilot study of the double-blind cross-over type].
    Hessö R; Thorell LH
    Nord Psykiatr Tidsskr; 1969; 23(5):496-9. PubMed ID: 4393979
    [No Abstract]   [Full Text] [Related]  

  • 86. Vascular hemichorea/hemiballismus and topiramate.
    Zesiewicz TA; Sullivan KL; Hauser RA
    Mov Disord; 2006 Apr; 21(4):581; author reply 582. PubMed ID: 16342173
    [No Abstract]   [Full Text] [Related]  

  • 87. Commentary on the article: "Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial" Foa EB et al., JAMA Psychiatry. 2022;79(3):193-200 (1).
    Fineberg NA; Hollander E; Grant JE; Chamberlain SR; Drummond LM; Pellegrini L; Laws KR; Wellsted D; Reid J; Nezgovorova V; Baldwin DS
    Compr Psychiatry; 2022 Jul; 116():152323. PubMed ID: 35537294
    [No Abstract]   [Full Text] [Related]  

  • 88. Carbamazepine in obsessive-compulsive disorder.
    Joffe RT; Swinson RP
    Biol Psychiatry; 1987 Sep; 22(9):1169-71. PubMed ID: 3651536
    [No Abstract]   [Full Text] [Related]  

  • 89. Trazodone in the treatment of obsessive-compulsive disorder: a case report.
    Kim SW
    J Clin Psychopharmacol; 1987 Aug; 7(4):278-9. PubMed ID: 3624515
    [No Abstract]   [Full Text] [Related]  

  • 90. The new biology of obsessive-compulsive disorder: implications for evolutionary psychology.
    Rapoport JL; Fiske A
    Perspect Biol Med; 1998; 41(2):159-75. PubMed ID: 9493398
    [No Abstract]   [Full Text] [Related]  

  • 91. Obsessive compulsive disorder.
    Hardy JL
    Can J Psychiatry; 1986 Apr; 31(3):290. PubMed ID: 3708519
    [No Abstract]   [Full Text] [Related]  

  • 92. Carbamezapine in obsessive-compulsive disorder.
    Khanna S
    Clin Neuropharmacol; 1988 Oct; 11(5):478-81. PubMed ID: 3219680
    [No Abstract]   [Full Text] [Related]  

  • 93. Medications to treat alcohol dependence: adding to the continuum of care.
    Willenbring ML
    JAMA; 2007 Oct; 298(14):1691-2. PubMed ID: 17925523
    [No Abstract]   [Full Text] [Related]  

  • 94. MAOI for obsessive compulsive disorder.
    Jenike MA
    Br J Psychiatry; 1982 May; 140():549. PubMed ID: 7104541
    [No Abstract]   [Full Text] [Related]  

  • 95. Commentary on Elkashef et al. (2012): just enough efficacy for a second look.
    Vocci F
    Addiction; 2012 Jul; 107(7):1307-8. PubMed ID: 22672376
    [No Abstract]   [Full Text] [Related]  

  • 96. Nardil response in a chronic obsessive compulsive.
    Annesley PT
    Br J Psychiatry; 1969 Jun; 115(523):748. PubMed ID: 5806868
    [No Abstract]   [Full Text] [Related]  

  • 97. Trazodone for bowel obsession.
    Ramchandani D
    Am J Psychiatry; 1990 Jan; 147(1):124. PubMed ID: 2293774
    [No Abstract]   [Full Text] [Related]  

  • 98. Scurvy, anemia and malnutrition secondary to obsessive-compulsive disorder.
    Yaegaschi MY; Torres AR
    Braz J Psychiatry; 2010 Jun; 32(2):198-9. PubMed ID: 20658062
    [No Abstract]   [Full Text] [Related]  

  • 99. Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders.
    Del Casale A; Kotzalidis GD; Rapinesi C; Girardi P
    Curr Neuropharmacol; 2019; 17(8):668-671. PubMed ID: 31393238
    [No Abstract]   [Full Text] [Related]  

  • 100. Coming out of the closet: a nurse with obsessive-compulsive disorder tells her story.
    Lindstrom S
    J Emerg Nurs; 1996 Oct; 22(5):469-71. PubMed ID: 8997979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.